[go: up one dir, main page]

CR11759A - Nueva clase de espiro piperidinas para el tratamiento de enfermedades neurodegenerativas - Google Patents

Nueva clase de espiro piperidinas para el tratamiento de enfermedades neurodegenerativas

Info

Publication number
CR11759A
CR11759A CR11759A CR11759A CR11759A CR 11759 A CR11759 A CR 11759A CR 11759 A CR11759 A CR 11759A CR 11759 A CR11759 A CR 11759A CR 11759 A CR11759 A CR 11759A
Authority
CR
Costa Rica
Prior art keywords
espiro
piperidines
treatment
neurodegenerative diseases
new class
Prior art date
Application number
CR11759A
Other languages
English (en)
Inventor
Michael Aaron Brodney
Chiristopher John Helal
Brian Thomas O'neill
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of CR11759A publication Critical patent/CR11759A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se desvelan compuestos y sales farmaceuticamente aceptables de los compuestos, teniendo los compuestos la estructura de la formula I, como se define en la memoria descriptiva.
CR11759A 2008-05-05 2010-10-26 Nueva clase de espiro piperidinas para el tratamiento de enfermedades neurodegenerativas CR11759A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5042308P 2008-05-05 2008-05-05

Publications (1)

Publication Number Publication Date
CR11759A true CR11759A (es) 2010-11-22

Family

ID=40902870

Family Applications (1)

Application Number Title Priority Date Filing Date
CR11759A CR11759A (es) 2008-05-05 2010-10-26 Nueva clase de espiro piperidinas para el tratamiento de enfermedades neurodegenerativas

Country Status (22)

Country Link
US (1) US20110046160A1 (es)
EP (1) EP2300484B1 (es)
JP (1) JP2011519913A (es)
KR (1) KR20110000749A (es)
CN (1) CN102083841A (es)
AP (1) AP2010005456A0 (es)
AT (1) ATE537178T1 (es)
AU (1) AU2009245322B2 (es)
BR (1) BRPI0912433A2 (es)
CA (1) CA2721786A1 (es)
CO (1) CO6321280A2 (es)
CR (1) CR11759A (es)
DO (1) DOP2010000317A (es)
EA (1) EA201001566A1 (es)
EC (1) ECSP10010597A (es)
ES (1) ES2375913T3 (es)
IL (1) IL208793A0 (es)
MA (1) MA32290B1 (es)
MX (1) MX2010012066A (es)
NZ (1) NZ588589A (es)
SV (1) SV2010003725A (es)
WO (1) WO2009136350A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7763609B2 (en) 2003-12-15 2010-07-27 Schering Corporation Heterocyclic aspartyl protease inhibitors
UA108363C2 (uk) 2009-10-08 2015-04-27 Похідні імінотіадіазиндіоксиду як інгібітори bace, композиція на їх основі і їх застосування
WO2011125006A2 (en) * 2010-04-09 2011-10-13 Pfizer Inc. Novel sultam compounds
US9221839B2 (en) 2011-04-07 2015-12-29 Merck Sharp & Dohme Corp. C5-C6 oxacyclic-fused thiadiazine dioxide compounds as BACE inhibitors, compositions, and their use
WO2012138590A1 (en) 2011-04-07 2012-10-11 Merck Sharp & Dohme Corp. Pyrrolidine-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use
KR20140054295A (ko) 2011-08-22 2014-05-08 머크 샤프 앤드 돔 코포레이션 Bace 억제제로서의 2-스피로-치환된 이미노티아진 및 그의 모노- 및 디옥시드, 조성물 및 그의 용도
EP3233799B1 (en) 2014-12-19 2021-05-19 The Broad Institute, Inc. Dopamine d2 receptor ligands
WO2016100940A1 (en) 2014-12-19 2016-06-23 The Broad Institute, Inc. Dopamine d2 receptor ligands

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE499373T1 (de) * 2004-01-08 2011-03-15 Hoffmann La Roche Diazaspiropiperidinderivate
JP2006044497A (ja) * 2004-08-05 2006-02-16 Toyota Motor Corp 車輪情報処理装置
US8114887B2 (en) * 2004-10-13 2012-02-14 Merck, Sharp & Dohme Corp. Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
ATE550338T1 (de) * 2005-07-18 2012-04-15 Merck Sharp & Dohme Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
CA2662776A1 (en) * 2006-09-07 2008-03-13 Merck And Co., Inc. Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
CA2673888A1 (en) * 2007-01-04 2008-07-17 Merck And Co., Inc. Bicyclic spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease

Also Published As

Publication number Publication date
EP2300484A1 (en) 2011-03-30
EA201001566A1 (ru) 2011-04-29
EP2300484B1 (en) 2011-12-14
AP2010005456A0 (en) 2010-12-31
CA2721786A1 (en) 2009-11-12
SV2010003725A (es) 2011-07-05
DOP2010000317A (es) 2010-11-15
AU2009245322B2 (en) 2011-07-14
JP2011519913A (ja) 2011-07-14
KR20110000749A (ko) 2011-01-05
MX2010012066A (es) 2010-12-06
WO2009136350A1 (en) 2009-11-12
CO6321280A2 (es) 2011-09-20
BRPI0912433A2 (pt) 2015-12-22
US20110046160A1 (en) 2011-02-24
AU2009245322A1 (en) 2009-11-12
MA32290B1 (fr) 2011-05-02
NZ588589A (en) 2012-07-27
ES2375913T3 (es) 2012-03-07
IL208793A0 (en) 2010-12-30
CN102083841A (zh) 2011-06-01
ECSP10010597A (es) 2010-12-30
ATE537178T1 (de) 2011-12-15

Similar Documents

Publication Publication Date Title
UY30500A1 (es) Compuestos de azabencimidazolilo
UY31189A1 (es) Compuestos heterocíclicos
CU20150062A7 (es) Lactamas n-(heteroarilo sustituido) fusionadas utiles en el tratamiento del crecimiento celular anormal
CR11759A (es) Nueva clase de espiro piperidinas para el tratamiento de enfermedades neurodegenerativas
CR20140399A (es) Pirrolidina-2-carboxamidas sustituidas
UY32977A (es) Novedosos compuestos como inhibidores de la caseina quinasa
CY1118662T1 (el) Νεες δικυκλικες πυριδινονες
PE20151788A1 (es) Inhibidores de bromodominios tetraciclicos
ECSP12012083A (es) Pirrolidina-2-carboxamidas sustituidas
PE20151023A1 (es) Triazolopirazinas
CO6361910A2 (es) Pirrolidina-2-carboxamidas sustituidas
CY1117745T1 (el) Ετεροκυκλικες ενωσεις και χρηση αυτων ως ρυθμιστες υποδοχεα τυπου iii κινασων τυροσινης
CU24087B1 (es) Compuestos de carbazol
CO6491060A2 (es) Compuestos y composiciones para el tratamiento de enfermedades parasitarias
NI201100096A (es) Lactamas como inhibidores de beta secretasa.
GT201200138A (es) Derivados de sulfonamida heterocíclicos útiles como inhibidores de mek
MX2012004311A (es) Derivados de ciclohexano spiro condensados como inhibidores de lipasa sensible a hormonas (hsl) utiles en el tratamiento de diabetes.
CU20110233A7 (es) Sulfonamidas heterocíclicas, usos y composiciones farmacéuticas de las mismas
CU20130139A7 (es) Derivados glocósidos y usos de los mismos
CU20110088A7 (es) Derivados de anilina-pirimidina sustituidos con sulfoximina como inhibidores de quinasas dependientes de ciclina (cdk), producción y uso de los mismos como productos medicinales
UY31775A (es) Compuestos heterocíclicos como inhibidores de mek
UY34043A (es) Isoxazolinas como agentes terapéuticos
ECSP11011217A (es) Microbiocidas nuevos.
CR20150148A (es) Azaindolinas
CU20110108A7 (es) [4-(1-amino-etil)-ciclohexil]-metil-aminas como antibacterianos

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)